FORT WORTH, Texas, Aug. 18 /PRNewswire-FirstCall/ — Wound
Management Technologies, Inc. (OTC Bulletin Board:
WNDM) announced today that its new international distributor,
Spiramed (Pty) Ltd, exhibited its advanced wound care collagen
product, CellerateRX® last weekend at the DFWG (Diabetic Foot
Working Group) congress in Cape Town and has already planned
exhibitions at two additional upcoming conferences. This
second meeting of the DFWG congress was attended by over 120
diabetic foot specialists. Spiramed will also be exhibiting
CellerateRX® at the UBUNTU International Conference-A Global
Wound Healing Initiative September 5-8. This conference is
hosted by South Africa and endorsed by the Wound Healing
Association of Southern Africa. Other supporting
organizations include the World Alliance of Wound and Lymphedema
Care, World Health Organization, The Lindsay Leg Club Foundation,
and Wound International. The programme is focused on
assessing the scope of wound care issues in economically challenged
countries and proposing strategies and solutions in the area of
wound care. They will also be showcasing CellerateRX® at
the VASSA 2010 Congress (Vascular Society of Southern Africa) in
October.
“We are excited about CellerateRX®’s introduction to the
South African market,” stated Cathy Bradshaw, President of Wound
Care Innovations, a subsidiary of Wound Management Technologies.
“According to the World Diabetes Foundation, the estimated
number of people with diabetes in South Africa is approximately
840,000, with a projected increase to 1.3 million in the next few
years. Statistics show that around 15% of these people will
develop a diabetic foot ulcer at some point in their lives.
We believe that CellerateRX® can have an enormous impact
in the management of the related wounds.”
CellerateRX®
‘/>”/>
SOURCE